Comprehensive genetic diagnosis of tandem repeat expansion disorders with programmable targeted nanopore sequencing.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
04 03 2022
Historique:
entrez: 4 3 2022
pubmed: 5 3 2022
medline: 20 4 2022
Statut: ppublish

Résumé

More than 50 neurological and neuromuscular diseases are caused by short tandem repeat (STR) expansions, with 37 different genes implicated to date. We describe the use of programmable targeted long-read sequencing with Oxford Nanopore's ReadUntil function for parallel genotyping of all known neuropathogenic STRs in a single assay. Our approach enables accurate, haplotype-resolved assembly and DNA methylation profiling of STR sites, from a list of predetermined candidates. This correctly diagnoses all individuals in a small cohort (

Identifiants

pubmed: 35245110
doi: 10.1126/sciadv.abm5386
pmc: PMC8896783
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

eabm5386

Références

Neuron. 2011 Oct 20;72(2):245-56
pubmed: 21944778
Brain. 2018 Aug 1;141(8):2280-2288
pubmed: 29939203
Genet Med. 2011 Jan;13(1):39-45
pubmed: 21116185
Brain. 2021 Mar 3;144(2):601-614
pubmed: 33374016
Muscle Nerve. 2007 May;35(5):681-4
pubmed: 17206657
Clin Pharmacol Ther. 2021 Sep;110(3):542-545
pubmed: 34091888
Front Neurol. 2019 Jul 03;10:710
pubmed: 31333565
Nature. 1991 Jul 4;352(6330):77-9
pubmed: 2062380
J Neurodev Disord. 2014;6(1):24
pubmed: 25110527
Am J Hum Genet. 2019 Jul 3;105(1):151-165
pubmed: 31230722
Biochim Biophys Acta. 2009 Jun;1790(6):467-77
pubmed: 19233246
Mov Disord Clin Pract. 2018 Nov 08;5(6):575-585
pubmed: 30637277
Neurotherapeutics. 2019 Oct;16(4):1106-1114
pubmed: 31755042
Genome Biol. 2018 Jul 13;19(1):90
pubmed: 30005597
Nat Methods. 2018 Jun;15(6):461-468
pubmed: 29713083
Nat Biotechnol. 2021 Apr;39(4):431-441
pubmed: 33257863
J Neurol. 2001 Jan;248(1):23-6
pubmed: 11266016
Mol Neurodegener. 2020 Jan 30;15(1):7
pubmed: 32000838
Eur J Hum Genet. 2010 Nov;18(11):1188-95
pubmed: 20179748
Nat Biotechnol. 2021 Apr;39(4):442-450
pubmed: 33257864
Clin Epigenetics. 2016 Dec 1;8:130
pubmed: 27980694
Mov Disord. 2012 Aug;27(9):1083-91
pubmed: 22692795
Mol Cell. 2020 Dec 3;80(5):915-928.e5
pubmed: 33186547
Clin Pharmacol Ther. 2021 Feb;109(2):352-366
pubmed: 32602114
Brain. 2020 Sep 1;143(9):2673-2680
pubmed: 32851396
Mov Disord. 2021 Jan;36(1):251-255
pubmed: 33026126
BMC Bioinformatics. 2020 Aug 5;21(1):343
pubmed: 32758139
Nat Biotechnol. 2022 Jul;40(7):1026-1029
pubmed: 34980914
Curr Opin Genet Dev. 2017 Jun;44:30-37
pubmed: 28213156
Handb Clin Neurol. 2017;144:107-111
pubmed: 28947109
Acta Neuropathol Commun. 2021 May 25;9(1):98
pubmed: 34034831
Nat Commun. 2019 Oct 11;10(1):4660
pubmed: 31604920
Nat Biotechnol. 2019 Dec;37(12):1478-1481
pubmed: 31740840
Neurology. 2020 Dec 15;95(24):e3394-e3405
pubmed: 32989102
Nat Genet. 1993 Jul;4(3):221-6
pubmed: 8358429
Genome Res. 2017 May;27(5):737-746
pubmed: 28100585
Nat Genet. 1994 Sep;8(1):88-94
pubmed: 7987398
Mov Disord. 2014 Sep 15;29(11):1359-65
pubmed: 25154728
Nucleic Acids Res. 1999 Jan 15;27(2):573-80
pubmed: 9862982
Nat Biotechnol. 2019 May;37(5):540-546
pubmed: 30936562
Science. 1996 Mar 8;271(5254):1423-7
pubmed: 8596916
Muscle Nerve. 2020 Aug;62(2):201-207
pubmed: 32270505
Nat Genet. 2019 Apr;51(4):649-658
pubmed: 30926972
JAMA Neurol. 2020 Mar 1;77(3):367-376
pubmed: 31738367
Front Genet. 2019 Nov 22;10:1219
pubmed: 31824583
Am J Hum Genet. 2018 Dec 6;103(6):858-873
pubmed: 30503517
J Med Genet. 2014 May;51(5):309-18
pubmed: 24591415
Nat Commun. 2019 Oct 29;10(1):4920
pubmed: 31664034
J Neurol Neurosurg Psychiatry. 2021 May;92(5):502-509
pubmed: 33452054
JAMA Neurol. 2020 Dec 1;77(12):1559-1563
pubmed: 32852534
Nat Genet. 2019 Aug;51(8):1222-1232
pubmed: 31332380
Ann Clin Transl Neurol. 2020 Apr;7(4):517-526
pubmed: 32250060
Nature. 2015 Oct 15;526(7573):343-50
pubmed: 26469045
Brain. 2021 Mar 3;144(2):584-600
pubmed: 33559681
PLoS Genet. 2013;9(7):e1003648
pubmed: 23935513
J Hum Genet. 2008;53(4):287-295
pubmed: 18301861
Mob DNA. 2020 Feb 17;11:11
pubmed: 32095164
Am J Hum Genet. 2021 Aug 5;108(8):1436-1449
pubmed: 34216551
Neurol Genet. 2021 Mar 12;7(2):e575
pubmed: 33977144
J Med Genet. 2019 Apr;56(4):265-270
pubmed: 30194086
Cell. 1993 Mar 26;72(6):971-83
pubmed: 8458085
Neuroepidemiology. 2016;46(3):191-7
pubmed: 26882032
Genome Biol. 2018 Aug 21;19(1):121
pubmed: 30129428
Nat Methods. 2015 Aug;12(8):733-5
pubmed: 26076426
Cold Spring Harb Perspect Med. 2019 Feb 1;9(2):
pubmed: 29844222
Nat Rev Genet. 2004 Jun;5(6):435-45
pubmed: 15153996
J Med Genet. 2019 Nov;56(11):758-764
pubmed: 31413119
Neuroepidemiology. 2014;42(3):174-83
pubmed: 24603320
Am J Hum Genet. 2009 Nov;85(5):544-57
pubmed: 19878914
Lancet Neurol. 2020 Nov;19(11):930-939
pubmed: 33098802
Hum Mol Genet. 1994 Jan;3(1):65-7
pubmed: 8162053
Bioinformatics. 2018 Sep 15;34(18):3094-3100
pubmed: 29750242
Nat Genet. 2019 Aug;51(8):1215-1221
pubmed: 31332381
J Med Genet. 1996 Dec;33(12):1007-10
pubmed: 9004132
Nat Rev Dis Primers. 2017 Sep 29;3:17065
pubmed: 28960184
Cell. 1991 May 31;65(5):905-14
pubmed: 1710175
Am J Hum Genet. 2021 May 6;108(5):764-785
pubmed: 33811808
Nat Genet. 1996 May;13(1):109-13
pubmed: 8673086
Brain. 2020 Oct 1;143(10):e82
pubmed: 32949124
F1000Res. 2018 Jun 13;7:
pubmed: 29946432
Neurobiol Aging. 2014 Feb;35(2):443.e1-3
pubmed: 24041967

Auteurs

Igor Stevanovski (I)

Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Sydney, NSW, Australia.

Sanjog R Chintalaphani (SR)

Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Sydney, NSW, Australia.
School of Medicine, University of New South Wales, Sydney, NSW, Australia.
St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.

Hasindu Gamaarachchi (H)

Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Sydney, NSW, Australia.
School of Computer Science and Engineering, University of New South Wales, Sydney, NSW, Australia.

James M Ferguson (JM)

Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Sydney, NSW, Australia.

Sandy S Pineda (SS)

Garvan-Weizmann Centre for Cellular Genomics, Garvan Institute of Medical Research, Sydney, NSW, Australia.
The University of Sydney, Brain and Mind Centre and School of Medical Sciences, Faculty of Medicine and Health, Camperdown, NSW, Australia.

Carolin K Scriba (CK)

Harry Perkins Institute of Medical Research, University of Western Australia, Nedlands, WA, Australia.
Diagnostic Genomics, PathWest Laboratory Medicine WA, Nedlands, WA, Australia.

Michel Tchan (M)

Westmead Hospital, Westmead, NSW, Australia and Sydney Medical School, The University of Sydney, NSW, Australia.

Victor Fung (V)

Westmead Hospital, Westmead, NSW, Australia and Sydney Medical School, The University of Sydney, NSW, Australia.

Karl Ng (K)

Department of Neurology, Royal North Shore Hospital and The University of Sydney, Sydney, NSW, Australia.

Andrea Cortese (A)

Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.
The National Hospital for Neurology and Neurosurgery, London, UK.

Henry Houlden (H)

Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.
The National Hospital for Neurology and Neurosurgery, London, UK.

Carol Dobson-Stone (C)

The University of Sydney, Brain and Mind Centre and School of Medical Sciences, Faculty of Medicine and Health, Camperdown, NSW, Australia.

Lauren Fitzpatrick (L)

The University of Sydney, Brain and Mind Centre and School of Medical Sciences, Faculty of Medicine and Health, Camperdown, NSW, Australia.

Glenda Halliday (G)

The University of Sydney, Brain and Mind Centre and School of Medical Sciences, Faculty of Medicine and Health, Camperdown, NSW, Australia.

Gianina Ravenscroft (G)

Harry Perkins Institute of Medical Research, University of Western Australia, Nedlands, WA, Australia.

Mark R Davis (MR)

Harry Perkins Institute of Medical Research, University of Western Australia, Nedlands, WA, Australia.

Nigel G Laing (NG)

Harry Perkins Institute of Medical Research, University of Western Australia, Nedlands, WA, Australia.
Diagnostic Genomics, PathWest Laboratory Medicine WA, Nedlands, WA, Australia.

Avi Fellner (A)

Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Sydney, NSW, Australia.
Raphael Recanati Genetics Institute, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.
The Neurology Department, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.

Marina Kennerson (M)

Northcott Neuroscience Laboratory, ANZAC Research Institute, Sydney, NSW, Australia.
Faculty of Health and Medicine, University of Sydney, Camperdown, NSW, Australia.
Molecular Medicine Laboratory, Concord Hospital, Concord, NSW, Australia.

Kishore R Kumar (KR)

Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Sydney, NSW, Australia.
Molecular Medicine Laboratory, Concord Hospital, Concord, NSW, Australia.
Neurology Department, Central Clinical School, Concord Repatriation General Hospital, University of Sydney, Concord, NSW, Australia.

Ira W Deveson (IW)

Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Sydney, NSW, Australia.
St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH